asia healthspace

A few weeks ago I posted a summary of research on the top 10 domestic medical device manufacturers in China. The full report which is far more comprehensive is now ready and can be downloaded from this link below: http://www.clearstate.com/asian-healthcare-titans-2013-medtech-china/ Tej Deol, MD., M.B.A.

China is the world’s most populous country with a population of over 1.35 billion. As of 2013, it also boasts the world’s second-largest economy by both nominal total GDP as well as by purchasing power parity (PPP). The nation is also the world’s largest exporter and importer of goods. In this report Clearstate studies the landscape [...]

Hospital markets country briefs China   We have explored the many trends driving the growth in China’s healthcare market in the above sections. With the recent policy change allowing 100% non-Chinese ownership of hospitals and other health services, foreign and private ventures in China’s healthcare sector is projected to increase over time. In fact, the [...]

Part 3 of the report Asia healthcare Titans 2013 from Clearstate Pte Ltd. Source: More than 10% stake, deal worth more than US$ 15 million, target country Asia. Unless otherwise indicated, source: Bloomberg & EIU Zephyr databases Tej Deol, M.D.

Supply drivers and trends in Asia   Strong demand inadequately met by current infrastructure At 2.08 beds and 1.09 doctors per 1,000 population, Asia and Australasia lags behind the global average (2.72 and 1.72 respectively, refer to Figure 6 below).[i] As Asia continues in its growth trajectory, demand will continue to outstrip supply. The market [...]

Demand drivers and trends in Asia GDP growth drives healthcare spending   With real GDP growth rates almost double the global average (5.70% compared to 2.30%[i]), Asia will be a prime driver of global economic growth going forward. At real GDP growth in the range of 5–8% in Asia annually, and with healthcare projected to [...]

The following series of posts describing the current landscape in the Hospital sector in prominent Asia Pacific markets are derived from a proprietary report developed by Clearstate. Clearstate, an Economist Intelligence Unit healthcare business, is the market leader in healthcare research-based consulting in the emerging markets. The analysis and content in this report is derived [...]

Interesting article (click link) in The Singapore Straits Times today on a topic of increasing relevance to Singaporeans as they grapple with demographic challenges with respect to native population maintenance. With advanced economic development and increasing work-place participation of women, birth rates have been falling steadily and are now below natural population replacement rates causing [...]

Hospitals, especially level 3 hospitals, are seeing disproportionately high patient volumes due to overwhelming patient preference over primary health facilities; RMB 16.5 bil budgeted for 2009-2011 to expand primary healthcare infrastructure and address the imbalance, implying a shift in growth opportunities from urban to rural / lower tier cities.

Malaysia’s government undergoing a strong push to extend national healthcare capabilities with emphasis on continued healthcare infrastructure development, as the National healthcare ecosystem is developed to propel economic growth. This initiative will include the planned construction of new hospitals and specialized facilities, including eight new hospitals, 156 rural clinics, 41 community health clinics, and 50 [...]